Efficacy and safety of a novel κ-agonist for managing intractable pruritus in dialysis patients

American Journal of Nephrology

Volumn 36, Issue 2, 2012, Pages 175-183

  Kumagai, Hiroo ^a   Ebata, Toshiya ^b   Takamori, Kenji ^c   Miyasato, Katsumasa ^d   Muramatsu, Taro ^e   Nakamoto, Hidetomo ^f   Kurihara, Masanao ^g   Yanagita, Tomoji ^h   Suzuki, Hiromichi ^f  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b Chitofuna Dermatology Clinic   (Japan)

^c JUNTENDO UNIVERSITY URAYASU HOSPITAL   (Japan)

^d Funomori Mental Clinic   (Japan)

^e KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f SAITAMA MEDICAL UNIVERSITY   (Japan)

^g Hibiya Takimura Clinic   (Japan)

^h JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Receptor agonist; Hemodialysis; Long term efficacy and safety; Nalfurafine hydrochloride; Pruritus

Indexed keywords

NALFURAFINE;

ACUTE PANCREATITIS; ADULT; AGED; ANEMIA; ARTICLE; CONSTIPATION; DIARRHEA; DISORIENTATION; DIZZINESS; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG DEPENDENCE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; ECZEMA; FEMALE; HEMODIALYSIS; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALAISE; MALE; MOOD CHANGE; OPEN STUDY; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PRURITUS; SIDE EFFECT; SOMNOLENCE; THYROTROPIN BLOOD LEVEL; VERTIGO; VOMITING;

AGED; DOUBLE-BLIND METHOD; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MORPHINANS; PATIENT SATISFACTION; PROSPECTIVE STUDIES; PRURITUS; QUESTIONNAIRES; RECEPTORS, OPIOID, KAPPA; RENAL DIALYSIS; SPIRO COMPOUNDS; TREATMENT OUTCOME;

EID: 84864527257     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000341268     Document Type: Article

References (21)

1. Ikoma A, Steinhoff M, Ständer S, Yosipovitch G, Schmelz M: The neurobiology of itch. Nat Rev Neurosci 2006;7:535-547. (Pubitemid 43995431)
2. Schwartz IF, Iaina A: Uraemic pruritus. Nephrol Dial Transplant 1999;14:834-839. (Pubitemid 29155130)
3. Mettang T, Pauli-Magnus C, Alscher DM: Uraemic pruritus - new perspectives and insights from recent trials. Nephrol Dial Transplant 2002;17:1558-1563. (Pubitemid 35012156)
4. Yosipovitch G, Greaves MW, Schmelz M: Itch. Lancet 2003;361:690-694. (Pubitemid 36253608)
5. Patel TS, Freedman BI, Yosipovitch G: An update on pruritus associated with CKD. Am J Kidney Dis 2007;50:11-20. (Pubitemid 46964882)
6. Pisoni RL, Wikström B, Elder SJ, Akizawa T, Asano Y, Keen ML, Saran R, Mendelssohn DC, Young EW, Port FK: Pruritus in haemodialysis patients: international results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2006;21:3495-3505. (Pubitemid 44817100)
7. Narita I, Alchi B, Omori K, Sato F, Ajiro J, Saga D, Kondo D, Skatsume M, Maruyama S, Kazama JJ, Akazawa K, Gejyo F: Etiology and prognostic significance of severe uremic pruritus in chronic hemodialysis patients. Kidney Int 2006;69:1626-1632.
8. Kumagai H, Saruta T, Matsukawa S, Utsumi J: Prospects for a novel κ-opioid receptor agonist, TRK-820, in uremic pruritus; in Yosipovitch G, Greaves MW, Fleischer JA, McGlone F (eds): Itch: Basic Mechanisms and Therapy. New York, Marcel Dekker, 2004, pp 279-286.
9. Dawn AG, Yosipovitch G: Butorphanol for treatment of intractable pruritus. J Am Acad Dermatol 2006;54:527-531. (Pubitemid 43245656)
10. Seki T, Awamura S, Kimura C, Ide S, Sakano K, Minami M, Nagase H, Satoh M: Pharmacological properties of TRK-820 on cloned mu-, delta-and kappa-opioid receptors and nociceptin receptor. Eur J Pharmacol 1999;376:159-167. (Pubitemid 29320181)
11. Nagase H, Hayakawa J, Kawamura K, Kawai K, Takezawa Y, Matsuura H, Tajima C, Endo T: Discovery of a structurally novel opioid kappa-agonist derived from 4, 5-epoxymorphinan. Chem Pharm Bull (Tokyo) 1998;46:366-369. (Pubitemid 28124231)
12. Wakasa Y, Fujiwara A, Umeuchi H, Endoh T, Okano K, Tanaka T, Nagase H: Inhibitory effects of TRK-820 on systemic skin scratching induced by morphine in rhesus monkeys. Life Sci 2004;75:2947-2957. (Pubitemid 39349259)
13. Togashi Y, Umeuchi H, Okano K, Ando N, Yoshizawa Y, Honda T, Kawamura K, Endoh T, Utsumi J, Kamei J, Tanaka T, Nagase H: Antipruritic activity of the kappa-opioid receptor agonist, TRK-820. Eur J Pharmacol 2002;435:259-264. (Pubitemid 34131709)
14. Umeuchi H, Togashi Y, Honda T, Nakao K, Okano K, Tanaka T, Nagase H: Involvement of central mu-opioid system in the scratching behavior in mice, and the suppression of it by the activation of kappa-opioid system. Eur J Pharmacol 2003;477:29-35. (Pubitemid 38366082)
15. Kamei J, Nagase H: Norbinaltorphimine, a selective kappa-opioid receptor antagonist, induces an itch-associated response in mice. Eur J Pharmacol 2001;418:141-145. (Pubitemid 32378821)
16. Wikström B, Gellert R, Ladefoged SD, Danda Y, Akai M, Ide K, Ogasawara M, Kawashima Y, Ueno K, Mori A, Ueno Y: Kappa-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies. J Am Soc Nephrol 2005;16:3742-3747. (Pubitemid 46211297)
17. Kumagai H, Ebata T, Takamori K, Muramatsu T, Nakamoto H, Suzuki H: Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a phase III, randomized, double-blind, placebo-controlled study. Nephrol Dial Transplant 2010;25:1251-1257.
18. Wahlgren CF, Ekblom A, Hägermark O: Some aspects of the experimental induction and measurement of itch. Acta Derm Venereol 1989;69:185-189. (Pubitemid 19110466)
19. Kawashima M, Tango T, Noguchi T, Inagi M, Nakagawa H, Harada S: Addition of fexofenadine to a topical corticosteroid reduces the pruritus associated with atopic dermatitis in a 1-week randomized, multicentre, doubleblind, placebo-controlled, parallel-group study. Br J Dermatol 2003;148:1212-1221. (Pubitemid 36819222)
20. Kurihara M, Jimbo M, Hirose T, Asano J, Endo S, Fujiya Y, Hada H, Haga M, Hasue I, Higuchi T, Karasumi H, Motomura H, Naito T, Nakamura R, Nakauchi M, Narita S, Noguchi T, Oyama K, Okada M, Okazaki Y, Sasaki K, Takahashi K, Takei H, Takeyama K, Watanabe J: Double-blind comparison of clinical effects of ID-540, (fludiazepam), diazepam and placebo on psychoneurotic patients and tentative draft of dependency questionnaire (in Japanese). Rinsho Hyoka 1977;5:341-368.
21. Johns LC: Hallucinations in the general population. Curr Psychiatry Rep 2005;7:162-167. (Pubitemid 40916407)